![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 3, 1739-1748, January 21, 2000
,
§,From the Center for Cardiovascular Research, University of Rochester, Rochester, New York 14642 and the § Department of Internal Medicine (First Division), Kobe University School of Medicine, Kobe 650-0017, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Reactive oxygen species and growth factors
stimulate similar intracellular signal transduction events including
activation of Src kinase family members and extracellular
signal-regulated kinases (ERK1/2). A potentially important downstream
effector of Src and ERK1/2 is p90 ribosomal S6 kinase (p90RSK), which
plays an important role in cell growth by activating several
transcription factors as well as the
Na+/H+ exchanger. In the present study,
we determined whether H2O2 activates p90RSK to
gain insight into signal transduction mechanisms activated by reactive
oxygen species. H2O2 (200 µM)
stimulated ERK1/2 and p90RSK activity in lymphocytes, endothelial
cells, and fibroblasts. The MEK-1 inhibitor, PD98059 (30 µM), inhibited H2O2-mediated activation of ERK1/2 but not of p90RSK. An essential role for Fyn and
Ras in p90RSK activation was suggested by five findings. 1) The
tyrosine kinase inhibitor, herbimycin A, and the specific Src kinase
family inhibitor, PP1, blocked p90RSK activation by H2O2 in a concentration-dependent
manner. 2) p90RSK activation by H2O2 was
significantly reduced in fibroblasts derived from transgenic mice
deficient in Fyn, but not c-Src. 3) H2O2
rapidly activated Ras (peak at 2-5 min), which preceded p90RSK
activation (peak at 20 min). 4) Dominant negative Ras completely
blocked H2O2-induced activation of p90RSK. 5)
In Fyn Reactive oxygen species
(ROS)1 including
H2O2, O p90RSK has multiple functions. In quiescent cells, inactive p90RSK
resides in the cytoplasm and is partially complexed with its upstream
regulator, ERK1/2 (11). Stimulation of cells by growth factors
operating through the Ras/Raf-1/MEK pathway leads to the activation of
ERK1/2, phosphorylation and activation of p90RSK, and the import of
these kinases into the nucleus. Whereas p90RSK was initially shown to
phosphorylate transcription factors, including c-Fos (12) and Nur77
(13), it has also been proposed that p90RSK is involved in activation
of nuclear factor- Previous studies have shown that c-Src is involved in signal events
stimulated by ROS (4). Several receptors that lack intrinsic tyrosine
kinase activity stimulate tyrosine phosphorylation through association
with Src family kinases such as Lck, Lyn, and Fyn (16). It has also
been reported that Src and Ras are critical for ERK1/2 activation by
H2O2 (17, 18). The predominant pathway for RSK
activation by growth factors has been proposed to involve
Src-Ras-Raf-Mek-ERK1/2. Interestingly, several investigators have
reported that there is an alternative pathway for p90RSK activation in
addition to ERK1/2 (19). Specifically, Li et al. (20)
reported that B cell receptor activation stimulates the tyrosine kinase
Syk, which activates p90RSK via an ERK1/2-independent pathway in DT40 cells.
To determine the role of Src family kinases in
H2O2-mediated activation of ERK1/2 and p90RSK,
we utilized specific Src inhibitors and cells derived from animals
deficient in c-Src and Fyn. We show here that activation of p90RSK by
H2O2 is positively regulated by Fyn but not by
c-Src. Furthermore, we demonstrate that Fyn is required for
H2O2-mediated activation of Ras. Thus, the
Fyn-Ras-p90RSK signaling pathway described here may represent a new
redox-sensitive mechanism.
Cell Lines, Culture, and Transfection--
Fibroblasts deficient
in c-Src (Src NHE-1 and Myelin Basic Protein Phosphorylation (In-gel Kinase
Assay)--
Equal amounts of cell lysate protein (20 µg) were
separated by 7.5% SDS-PAGE in a gel containing 0.15 mg/ml of GST-NHE-1
(625-747) or 1.0 mg/ml of myelin basic protein. We have previously
shown that results for in-gel kinase assay and immune complex kinase assay for ERK1/2 are highly correlated (R2 = 0.92) (25). The gel was then incubated twice in Buffer A (50 mmol/liter
HEPES, pH 7.4, and 5 mmol/liter Immunoprecipitation and Western Blot Analysis--
After
treatment, the cells were washed with phosphate-buffered saline,
harvested in 0.5 ml of lysis buffer (50 mM sodium
pyrophosphate, 50 mM NaF, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, 100 µM
Na3VO4, 10 mM HEPES, pH 7.4, 0.1%
Triton X-100, 500 µM phenylmethylsulfonyl fluoride, and
10 µg/ml leupeptin), and flash-frozen on a dry ice/ethanol bath.
After allowing the cells to thaw, cells were scraped off the dish and
centrifuged at 14,000 × g (4 °C for 30 min), and protein concentration was determined using the Bradford protein assay
(Bio-Rad). For immunoprecipitation, cell lysates were incubated with
goat anti-p90RSK2 antibody for 3 h at 4 °C and then incubated with 20 µl of protein A-Sepharose CL-4B (Amersham Pharmacia Biotech) for 1 h on a roller system at 4 °C. The beads were washed two times with 1 ml of lysis buffer, two times with 1 ml of LiCl wash buffer (500 mM LiCl, 100 mM Tris-Cl, pH 7.6, 0.1% Triton X-100, 1 mM dithiothreitol), and two times in
1 ml of washing buffer (20 mM HEPES, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 1 mM dithiothreitol, 0.1% Triton X-100). For Western blot
analysis, immunoprecipitates were subjected to SDS-PAGE, and proteins
were transferred to nitrocellulose membranes (HybondTM-ECL,
Amersham Pharmacia Biotech) as described previously (26). The membrane
was blocked for 1 h at room temperature with a commercial blocking
buffer from Life Technologies, Inc. The blots were then incubated for
4 h at room temperature with the p90RSK or ERK1/2 (Santa Cruz
Biotechnology) antibody, followed by incubation for 1 h with
secondary antibody (horseradish peroxidase-conjugated). For ERK1/2
activation, the blots were incubated for 12 h with anti-phospho-specific ERK1/2 (New England Biolabs) or nonspecific ERK1
and ERK2 antibodies (Santa Cruz Biotechnology). Immunoreactive bands
were visualized using enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech).
p90RSK Kinase Assays--
p90RSK kinase activity was measured by
GST-NHE-1 phosphorylation as described previously with slight
modification (9, 26). Cells were harvested in lysis buffer at 4 °C
and then flash-frozen on a dry ice/ethanol bath. After allowing the
cells to thaw, cells were scraped off the dish and centrifuged at
14,000 × g (4 °C for 30 min), and protein
concentration was determined. p90RSK was immunoprecipitated by
incubating 400 µg of protein from each sample with 3 µl of the goat
anti-p90RSK2 (Santa Cruz Biotechnology) antibody for 3 h, adding
40 µl of a 1:1 slurry of protein A-Sepharose (Amersham Pharmacia
Biotech) beads to the extract-antibody mixture, and incubating for
1 h at 4 °C. The beads were washed two times with 1 ml of lysis
buffer, two times with 1 ml of LiCl wash buffer (500 mM
LiCl, 100 mM Tris-Cl, pH 7.6, 0.1% Triton X-100, 1 mM dithiothreitol), and two times in 1 ml of modified
Buffer A (20 mM HEPES, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 1 mM dithiothreitol, 0.1% Triton X-100). Immunoprecipitated RSK was resuspended in 25 mmol/liter HEPES, pH 7.4, 10 mmol/liter MgCl2, 10 mmol/liter MnCl2, and the kinase reaction was initiated by
addition of 200 pmol of GST-NHE-1 (625-747), 15 µmol/liter ATP, and
0.5 mCi/ml of [ Measurement of Intracellular [Ca2+]i by
Fura 2--
Measurement of [Ca2+]i was performed
as described previously (27, 28). Briefly, a Jurkat T-cell suspension
(approximately 2 × 106 cells/ml) was loaded with 2 µM fura 2/AM for 30 min at room temperature. After the
loading period, the T-cells were washed twice with Krebs-Ringer-HEPES (KRH) medium containing 0.2% bovine serum albumin. The composition of
KRH is as follows: 120 mM NaCl, 5.4 mM KCl, 1.0 mM CaCl2, 0.8 mM MgCl2,
11.1 mM glucose, 20 mM HEPES, pH 7.4. The
fluorescence of the fura 2-loaded cell suspension was monitored in the
cuvette with a PTI Delta scan spectrofluorometer. The excitation
wavelengths were 340 and 380 nm, and emission was measured at 510 nm.
[Ca2+]i was estimated as described by Grynkiewicz
et al. (29). [Ca2+]i (in
nM) = 225 nM × (F Activated Ras Affinity Precipitation Assay--
The expression
vector encoding the fusion protein GST-Raf binding domain (GST-RBD) was
obtained by ligation of cDNA encoding the first 149 amino acids of
Raf-1 into the SmaI site of the pGEX 2T vector (Amersham
Pharmacia Biotech). GST-RBD expression was induced in transformed
bacteria with 1 mM isopropyl
Analysis of Ras-bound GDP and GTP--
Cells at 70-80%
confluence in 60-mm dishes were growth-arrested by incubation in
phosphate-free Dulbecco's modified Eagle's medium for 18 h prior
to use. The quiescent cells were washed once with 2 ml of
phosphate-free Dulbecco's modified Eagle's medium. The cells were
incubated with phosphate-free Dulbecco's modified Eagle's medium
supplemented with 0.1-0.2 mCi/ml [32P]orthophosphate for
6 h. Sodium orthovanadate (50 µM) was added to the
cells during the last 30 min to increase GTP-bound Ras as described
(31). The cells were then stimulated with H2O2 for the indicated periods of time. After lysis of the cells, Ras was
immunoprecipitated from the cell lysates with anti-Ras monoclonal antibody Y13-259 and analyzed as described by Satoh et al.
(32).
Materials--
All materials were from Sigma except as
indicated. H2O2 was from Fisher Scientific, and
PP1 was from Pfizer.
Statistical Analysis--
Data are reported as mean ± S.D.
Statistical analysis was performed with the StatView 4.0 package
(ABACUS Concepts, Berkeley, CA). Differences were analyzed with
unpaired two-tailed Student's t test or with Welch's
t test as appropriate.
H2O2 Stimulates p90RSK Activity in Human
Blood Peripheral Mononuclear Cells--
A role for p90RSK in ROS
signal transduction was first suggested by experiments to identify
kinases that phosphorylate NHE-1. MNCs were stimulated with
H2O2 or sorbitol, and cell lysates were subjected to an in-gel-kinase-assay using GST-NHE-1 (625-747) as
substrate. H2O2 stimulated the activity of
several NHE-1 kinases in human MNCs, including kinases of 90, 60, 44, and 42 kDa (Fig. 1). The kinase activated
to the greatest extent by H2O2 was a 90-kDa
kinase. Of interest, the activity of the 90 kDa kinase was stimulated
by H2O2 but not by sorbitol. In rat vascular
smooth muscle cells, we showed previously that p90RSK is the
predominant 90-kDa NHE-1 kinase by immunodepletion of RSK with RSK2
antibody (9). To identify which RSK isoforms were present in human
MNCs, Western blot analysis was performed. Immunoreactive 90-kDa
protein bands were readily observed with each p90RSK isoform antibody (Fig. 1B). To confirm that p90RSK was activated by
H2O2, we performed an immune complex kinase
assay using GST-NHE-1 as substrate. Immunoprecipitated p90RSK showed a
concentration-dependent increase in activity at 5 min after
stimulation by H2O2 (Fig. 1C). To
confirm that the increase in p90RSK activity (measured by immune
complex GST-NHE-1 phosphorylation) was not due to ERK1/2 that
co-precipitated with p90RSK, we immunoprecipitated with p90RSK antibody
and then performed a Western blot with anti-ERK1/2 antibody (Fig.
1D). We could not detect ERK1/2 in p90RSK
immunoprecipitates, indicating that p90RSK is the dominant NHE-1 kinase
present.
p90RSK Can Be Regulated via a MEK1/2-independent Pathway--
To
determine whether activation of p90RSK by H2O2
was ubiquitous, we measured the response to
H2O2 in several different cell types.
Growth-arrested Jurkat T-cells, bovine aortic endothelial cells (BAEC),
and mouse fibroblasts were analyzed by Western blotting with p90RSK
antibody. There was equal expression of p90RSK in all cell types
studied (Fig. 2A). Exposure to
200 µM H2O2 stimulated p90RSK
activity in both Jurkat cells (12.6-fold at 5 min) and BAEC (3.6-fold
at 20 min). A much smaller response was observed in mouse
fibroblasts.
We previously reported that activation of p90RSK by angiotensin II and
platelet-derived growth factor was inhibited by PD98059 (MEK1/2
inhibitor), suggesting that this kinase is regulated by the
MEK1/2-ERK1/2 pathway. To determine the role of MEK1/2-ERK1/2 in p90RSK
activation, the time course for ERK1/2 activation by 200 µM H2O2 was determined. In
fibroblasts, we used both an in-gel kinase assay and immunoblotting for
dually phosphorylated, active ERK1/2 in whole cell lysates. Stimulation
of fibroblasts with H2O2 caused maximal
activation of ERK1/2 at 5 min (Fig. 2B, left, top panel).
Activated ERK1/2 could also be detected in immunoblots of lysates from
fibroblasts stimulated with H2O2, confirming
the results of in-gel kinase assay. Griffith et al. (33)
have reported that an immune complex kinase assay correlates well with
immunoblotting for active phosphorylated ERK1/2 in Jurkat T cells. In
addition, we found that activation of ERK1/2 by in-gel kinase assay and immunoblotting for active ERK1/2 were highly correlated
(R2 = 0.90) in endothelial cells (data not
shown). Therefore, we used immunoblotting for phospho-ERK1/2 to
evaluate ERK1/2 activation as described previously (33-35). Because in
Jurkat cells ERK1 (44-kDa) is not expressed to the same extent as ERK2
(42-kDa), phosphorylated ERK1 is less prominent than ERK2 as reported
by others (33, 36-40). After H2O2 stimulation,
ERK1/2 activity rapidly increased with a peak at 2-5 min (Fig.
2B), which preceded peak activity of p90RSK in both Jurkat
cells (5 min) and mouse fibroblasts (20 min). In contrast, p90RSK
activity in BAEC increased rapidly at 5 min after
H2O2 stimulation, but ERK1/2 activity did not
increase until 20 min, significantly slower than the peak of p90RSK
activity. These results suggest that there is an alternative pathway,
besides ERK1/2, for activation of p90RSK in BAEC.
To define the role of MEK1/2-ERK1/2 in
H2O2-mediated activation of p90RSK, we
determined the effect of PD98059 on both ERK1/2 and p90RSK activity in
Jurkat cells. PD98059 caused a concentration-dependent inhibition of H2O2-mediated ERK1/2 activation
with an IC50 value of ~1 µM. At 30 µM PD98059, ERK1/2 inhibition was ~78%. In contrast, p90RSK activation was only partially inhibited by PD98059, ~26% at
30 µM (Fig.
3B).
To determine whether ERK1/2 inhibition by PD98059 was sufficient to
attenuate p90RSK activity, we compared the effect of PD98059 on ERK1/2
and p90RSK activities stimulated by H2O2 and
the Ca2+ ionophore A23187 (which is known to stimulate
p90RSK activity in an ERK1/2-dependent manner (41)). A23187
(60 µM) activated both ERK1/2 and p90RSK (Fig.
4). PD98059 inhibited ERK1/2 and p90RSK
activation by A23187 in a dose-dependent manner, with
complete inhibition by 30 µM PD98059. These results show
that inhibiting ERK1/2 activation with PD98059 significantly attenuates
p90RSK activation. In combination, the results suggest that
H2O2-mediated p90RSK activation is regulated,
at least partially, via MEK1/2-independent pathways, whereas
A23187-mediated p90RSK activation is completely MEK1/2-dependent.
Role of PKC and Calcium in H2O2-mediated
p90RSK Activation in Jurkat Cells--
Increases in intracellular
calcium modulate long-term cellular responses by regulating the
function of several transcription factors, thus leading to new gene
expression (42). In particular, CREB, which is phosphorylated and
regulated by p90RSK, is a critical mediator of
Ca2+-dependent gene expression (43). Because
H2O2 increases [Ca 2+]i,
and because we previously found that
H2O2-mediated c-fos expression was
dependent on both calcium and protein kinase C (7), we determined
whether p90RSK activation by H2O2 was calcium-
and protein kinase C-dependent (Fig.
5).
We previously found that p90RSK does not require the activity of
phorbol ester-responsive PKC isoforms for stimulation by angiotensin II
in vascular smooth muscle cells, as shown by the failure of PKC
down-regulation (incubation with 1 µM phorbol
12,13-dibutyrate for 24 h) to inhibit activity. As shown in Fig.
5A, down-regulation of PKC partially inhibited ERK1/2 and
p90RSK activation by H2O2 in Jurkat cells. In
contrast, phorbol 12-myristate 13-acetate-mediated activation of ERK1/2
and p90RSK was completely inhibited by phorbol 12,13-dibutyrate treatment.
To prevent increases in intracellular calcium, we used BAPTA-AM.
Following BAPTA-AM treatment, H2O2 was no
longer able to stimulate p90RSK in Jurkat cells (Fig. 5B, bottom
panel). In contrast, Ca2+ chelation did not inhibit
ERK1/2 activation by H2O2 (Fig. 5B, top
two panels) as described previously (17). These results confirm
that in addition to MEK1/2-ERK1/2, there is an alternative pathway for
H2O2-mediated p90RSK activation via a
calcium-dependent pathway. A23187-induced increases in
cytosolic Ca2+ are very different from physiological
changes. Therefore, we performed two sets of experiments to define the
role of Ca2+ in H2O2-induced p90RSK
activation. First, we determined the effect of BAPTA-AM,
H2O2 (200 µM), thapsigargin (a
microsomal Ca2+-ATPase inhibitor), and A23187 on
[Ca2+]i. Second, we compared p90RSK activation by
thapsigargin and H2O2 in Jurkat cells.
The basal level of [Ca2+]i was 85 ± 12 nM in Jurkat T-cells, and pretreatment with 75 µM BAPTA-AM chelated [Ca2+]i to
3 ± 2 nM. 100 nM thapsigargin elevated
[Ca2+]i to 320 ± 28 nM, and 60 µM A23187 increased [Ca2+]i to
1944 ± 387 nM (in the presence of 1.0 mM
extracellular CaCl2). In contrast,
H2O2 (200 µM) did not increase
[Ca2+]i significantly (116 ± 24 versus 85 ± 12 nM (p = 0.12; n = 3)) in Jurkat T-cells.
To define the the role of "physiological" increases in
[Ca2+]i on p90RSK activation, we also determined
the effect of thapsigargin on p90RSK activation. Whereas
H2O2 (200 µM) stimulated p90RSK
very strongly (Fig. 6), 100 nM thapsigargin only weakly activated p90RSK, despite
increasing [Ca2+]i to a greater extent. These
results suggest that Ca2+-sensitive proteins that require a
basal level of [Ca2+]i are involved in
H2O2-induced p90RSK activation, because pretreatment of BAPTA-AM completely inhibited p90RSK activation by
H2O2. However, increases in
[Ca2+]i are not required for
H2O2-mediated p90RSK activation in
Jurkat-T-cells, because 200 µM
H2O2 did not increase
[Ca2+]i significantly, and
[Ca2+]i increased by thapsigargin did not
activate p90RSK to the same extent as H2O2.
Both Herbimycin A and PP1 Inhibit p90RSK Activation by
H2O2 in Jurkat Cells--
Previous
investigators have suggested that several tyrosine kinases in addition
to c-Src may be upstream mediators of redox-sensitive signal
transduction (4). Western blot analysis of total cell lysates showed
that H2O2 stimulated tyrosine phosphorylation
of 40-, 50-, 60-, 66-, and 110-kDa proteins (Fig.
7A). To determine whether a
Src family kinase is an upstream mediator of p90RSK, we studied the
effect of two different inhibitors, herbimycin A (a nonspecific
tyrosine kinase inhibitor) and PP1 (a specific Src family kinase
inhibitor) on H2O2-mediated p90RSK activity (Fig. 7B). Both herbimycin A and PP1 inhibited
H2O2-mediated p90RSK activation in Jurkat cells
in a dose-dependent manner with an IC50 value
of ~0.3 µM (Fig. 7B).
Activation of p90RSK in Response to H2O2 Is
Dependent on Fyn, but Not on c-Src--
The ability of herbimycin A
and PP1 to inhibit p90RSK activation by H2O2
suggested an important role for Src family kinases. To verify the role
of a Src family kinase-dependent mechanism, we utilized
cells derived from mice deficient in Src or Fyn (21). There was no
immunoreactive c-Src in Src
To evaluate the role of ERK1/2 in p90RSK activation by
H2O2 in these fibroblasts, we investigated
ERK1/2 activation stimulated by H2O2 in
Src Role of Ras in p90RSK and ERK1/2 Activation by
H2O2--
Many studies indicate that tyrosine
kinases activate ERK1/2 via a Ras-dependent mechanism (6,
44). To determine whether Ras is a component of the signaling cascade
leading to p90RSK or ERK1/2 activation by H2O2,
we examined the effect of dominant negative Ras (RasN17) on ERK1/2 and
p90RSK activation in Chinese hamster ovary cells. Overexpression of
RasN17 completely blocked ERK1/2 and p90RSK activation by
H2O2, suggesting that Ras is required for
H2O2-induced activation of p90RSK and
ERK1/2 (Fig. 10).
Role of Fyn in Ras Activation--
The activity of Ras is
regulated through binding of guanine nucleotides, the GTP-bound active
form of protein being able to interact with effector proteins such as
Raf-1 and PI3-K (45). The kinetics of H2O2
stimulated Ras activation have, as yet, not been studied. In the
present study, Ras activation was assessed by monitoring the
association between Ras-GTP and the RBD of Raf (30). Cell lysates of
mouse fibroblasts stimulated with H2O2 were
subjected to affinity precipitation with GST-RBD protein. The eluted
proteins were then subjected to SDS-PAGE and immunoblotted with
anti-Ras antibody. Stimulation of fibroblasts with
H2O2 caused maximal activation of Ras at 2 min,
as measured by GST-RBD association (Fig.
11A). In contrast, in
Fyn
To confirm that GST-RBD accurately measures endogenous Ras activity, we
also determined the formation of RasGTP by the GTP labeling technique
(46). In response to H2O2, the fraction of GTP-bound Ras was increased from 23% to ~ 80% with peak at
2-5 min (Fig. 11C). There was complete inhibition of Ras
activation by H2O2 in Fyn The major findings of this study are that
H2O2 stimulates p90RSK in a Fyn- and
Ras-dependent manner. Redox-sensitive regulation of p90RSK
is thus a new function for Fyn. Data that support an essential role for
Fyn and Ras in H2O2-mediated p90RSK activation include the following. 1) Tyrosine kinase and specific Src family kinases inhibitors, herbimycin A and PP1, blocked p90RSK activation by
H2O2 at concentrations consistent with a
specific effect on Src family kinases. 2) In Fyn Based on the present study and previous work from our lab and other
investigators we propose a scheme (Fig.
12) for ROS-mediated signal
transduction leading to activation of mitogen-activated protein kinases
and p90RSK. A novel aspect of this model is that activation of the
tyrosine kinases c-Src and Fyn stimulates specific pathways leading to
selective activation of BMK1/ERK5 by c-Src and activation of ERK1/2 and
p90RSK by Fyn. Previous investigators have suggested that Src family
kinases are upstream mediators of redox-sensitive signal transduction
based on findings with UV irradiation (4). There are at least nine
members of the Src family of cytoplasmic protein kinases. The function
of each individual member has been revealed by genetic analysis in
mice, which showed partial overlapping function among the Src family members during development (21, 47, 48). Previously we found that c-Src
but not Fyn was required for H2O2-mediated
BMK1/ERK5 activation in fibroblasts (49). In contrast, in the present study, we found that Fyn but not c-Src was required for
H2O2-mediated p90RSK activation in fibroblasts.
These results indicate that c-Src and Fyn have separate roles in
ROS-mediated signal transduction (Fig. 12). Future studies will be
required to define the precise nature of the downstream substrates for
c-Src and Fyn.
/
fibroblasts, activation of Ras by
H2O2 was significantly attenuated. These
results show essential roles for Fyn and Ras in
H2O2-mediated activation of p90RSK and
establish redox-sensitive regulation of Ras and p90RSK as a new
function for Fyn.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2, and OH
have
been implicated in the pathogenesis of cardiovascular disease, especially atherosclerosis and hypertension (1-3). Recently, it has
been shown that ROS stimulate intracellular signal events similar to
those activated by growth factors, including activating kinases such as
c-Src and ERK1/2 (4, 5). Several transcription factors, including
nuclear factor-
B and c-fos, also appear to be activated by ROS (6,
7). Furthermore, several investigators have shown that
H2O2 stimulates both ERK1/2 and the
Na+-H+ exchanger (NHE-1) in cardiac myocytes
(8). Previously, we showed that p90RSK was a putative NHE-1 kinase and
that increased p90RSK activity correlated with increased
Na
/H+ exchange activity in hypertensive rats
(9, 10). These findings suggest that p90RSK may be an important
mediator of ROS function.
B by phosphorylation of I
-B (14). Recently,
p90RSK has been reported to have both positive and negative regulatory
effects on cyclic AMP response element-binding proteins (CREBs).
Specifically, p90RSK2, one of three closely related rsk genes
(rsk1, rsk2, and rsk3), has been shown to
function as a stimulus-coupled CREB kinase by phosphorylating serine
133, which regulates CREB activity (15). Thus, the upstream signal
mechanisms by which H2O2 activates p90RSK should provide valuable insights into pathways of redox-sensitive signal transduction.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/
) or Fyn (Fyn
/
) were isolated from mouse embryo
fibroblasts homozygous for disruption of the Src and Fyn genes,
immortalized with large T antigen (21). Cells were kindly provided by
Sheila M. Thomas (Fred Hutchinson Cancer Center, Seattle, WA).
Fibroblasts were maintained in Dulbecco's modified Eagle's medium
supplemented with 10% calf serum as described previously (21). The
dominant negative Ras (generously provided by Dr. Neil Nathanson,
University of Washington, Seattle, WA) (22) was subcloned into
pcDNA3.1(+) (Invitrogen Inc.) to transfect mammalian cells.
LipofectAMINE transfections were performed as described previously
(23). Cells at 70-80% confluence in 100-mm dishes were
growth-arrested by incubation in RPMI 1640 medium for 24 h prior
to use. Human peripheral blood mononuclear cells (MNCs) were obtained
from healthy, normal subjects by Ficoll-Paque Plus (Amersham Pharmacia
Biotech) density gradient centrifugation as described previously (24).
By Giemsa and
-naphthyl butyrate esterase staining, we found
78.4 ± 6.2% lymphocytes, 20.2 ± 7.5% monocytes,
occasional granulocytes (0.8 ± 0.4%), and clumps of platelets
(n = 5) contained in the MNC preparation. Jurkat cells were serum-starved for 16 h before being harvested and washed in
4 °C RPMI medium using minimal manipulation of the cells, because it
was noted that extensive manipulation of the cells resulted in high
basal ERK activity. The cells were resuspended at 6 × 107 cells/ml and quickly stimulated with
H2O2, phorbol 12-myristate 13-acetate, or thapsigargin.
-mercaptoethanol) containing 20%
isopropyl alcohol for 30 min, once in Buffer A for 1 h, twice in
Buffer A containing 6 M guanidine HCl for 30 min, twice in
Buffer A containing 0.04% Tween 20 at 4 °C for 16 and 2 h,
once in Buffer A containing 100 µmol/liter
Na3VO4 and 10 mmol/liter MgCl2 at
30 °C for 30 min, and once in Buffer A containing 100 µmol/liter
Na3VO4 and 10 mmol/liter MgCl2, 50 µmol/liter ATP, and 50 µCi of [
-32P]ATP for 1 h at 30 °C. The reaction was terminated by washing the gel 6-8
times in fixative solution containing 10 mmol/liter sodium
pyrophosphate and 5% trichloroacetic acid for 15 min. The gel was
dried and subjected to autoradiography. Autoradiographic signal
intensity was quantified by densitometry in the linear range of film
exposure by using a LaCie scanner and NIH Image 1.49.
-32P]ATP. After the reaction proceeded
for 20 min at 30 °C, it was terminated by addition of Laemmli sample
buffer, and proteins were analyzed by 10% SDS-PAGE, followed by autoradiography.
Fmin)/(Fmax
F), where F was the measured fluorescence
intensity, Fmax was the fluorescence intensity
after cell lysis, and Fmin was the fluorescence
intensity in the presence of 10 mM EGTA and 75 µM BAPTA-AM.
-D-thiogalactoside for 1 h, after which time,
bacteria were harvested and lysed by sonication. The GST-RBD fusion
protein was then purified on glutathione-Sepharose beads. Affinity
precipitation of activated Ras was performed as described previously
(30). Briefly, lysates were incubated on a rocker plate at 4 °C for
1 h with GST fusion protein bound to glutathione-Sepharose beads.
Then, the supernatant containing equal amounts of protein after
centrifugation was incubated with 50-60 µg of GST-RBD bound to beads
at 4 °C for 4 h. The beads were then extensively washed with 20 mM HEPES, pH 7.5, 120 mM NaCl, 10% glycerol,
0.5% Triton X-100, 2 mM EDTA, 10 µg/ml leupeptin, and 10 µg/ml aprotinin. The eluted proteins were resolved on 12.5% polyacrylamide gel. Coomassie Brilliant Blue was used to stain the
fusion protein in the gel (molecular mass, 42 kDa). Bound Ras was
quantified by Western blot analysis as described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (43K):
[in a new window]
Fig. 1.
p90RSK is activated by oxidative stress.
A, human peripheral mononuclear cells were stimulated for 5 min with 0.4 M sorbitol or 200 µM
H2O2. Cells were harvested in lysis buffer as
described under "Materials and Methods," and in-gel kinase assay
was performed with GST-NHE-1 (625-747) as substrate. B,
human peripheral mononuclear cells were harvested, cell lysates were
prepared, and Western blot analysis was performed with polyclonal goat
antibodies against RSK1, RSK2, and RSK3. C, human peripheral
mononuclear cells were stimulated for 5 min with the indicated
concentrations of H2O2. Cells were harvested in
lysis buffer, and proteins were immunoprecipitated with RSK2 antibody
and phosphorylation of GST-NHE-1 (625-747) was determined by in
vitro kinase assay. D, human peripheral mononuclear
cells were stimulated for 5 min with 200 µM
H2O2. Cells were harvested in lysis buffer, and
proteins were immunoprecipitated with RSK2 antibody and Western blot
analysis was performed with RSK2 (top panel) or ERK1/2
(bottom panel) antibody. TCL, total cell lysates.
Data shown are representative of experiments repeated two times with
different samples.

View larger version (49K):
[in a new window]
Fig. 2.
p90RSK and ERK1/2 is activated by
H2O2 in multiple cell types. A,
Western blot analysis. Jurkat cells, BAEC, mouse fibroblasts, and
mononuclear cells were obtained and grown as described under
"Materials and Methods." Western blot analysis was performed on
whole cell lysates using RSK2 antibodies. B, ERK1/2 and
p90RSK activation by H2O2. The indicated cells
were growth-arrested for 48 h as described under "Materials and
Methods" and then exposed to 200 µM
H2O2 for the indicated times. ERK1/2 activity
was measured by in-gel kinase assay as described under "Materials and
Methods" in fibroblasts (left, top panel) and Western blot
analysis with a phospho-specific ERK antibody that recognizes only the
catalytically activated forms (phosphorylated on
Thr202/Tyr204) of ERK1/2 (left, second
panel from top; right, top panel of Jurkat
and BAEC). Levels of total ERK1/2 in the same samples were
measured with anti-ERK1/2 antibodies (IB: ERK1/2).
Bottom panels of each set, p90RSK activity was
measured by in vitro kinase assay using GST-NHE-1 (625-747)
as substrate. Data shown are representative of experiments repeated two
times with different samples.

View larger version (23K):
[in a new window]
Fig. 3.
MEK1/2 inhibition prevents
H2O2-mediated activation of ERK1/2 to a greater
extent than activation of p90RSK. Growth-arrested Jurkat T-cells
were treated with varying concentrations of PD98059 or vehicle (0.1%
dimethyl sulfoxide) for 30 min and then stimulated with 200 µM H2O2 for 5 min. Cell lysates
were prepared, lysate proteins were immunoprecipitated with RSK2
antibody, and in vitro kinase assay with GST-NHE-1
(625-747) as substrate was performed. ERK1/2 activity was measured by
Western blot analysis with a phospho-specific ERK antibody. After
SDS-PAGE, phosphorylation of GST-NHE-1 (625-747) and ERK1/2 was
measured by densitometry in the linear range of film development.
A, representative Western blot with anti-phospho-specific
ERK1/2 antibody (top panel) and anti-ERK1/2 (middle
panel) and autoradiogram for p90RSK activity (bottom
panel). B, densitometric analysis of ERK1/2 and
GST-NHE-1 (625-747) phosphorylation. Results were normalized to
control (time = 0), which was arbitrarily set to 1.0 (shown is
mean ± S.D., n = 3).

View larger version (23K):
[in a new window]
Fig. 4.
A23187 activates ERK1/2 and p90RSK:
inhibition by PD98059. Growth-arrested Jurkat cells were treated
with varying concentrations of PD98059 or vehicle (0.1% dimethyl
sulfoxide) for 30 min and then stimulated with 60 µM
A23187 for 5 min. Cell lysates were prepared, lysate proteins were
immunoprecipitated with RSK2 antibody, and in vitro kinase
assay with GST-NHE-1 (625-747) as substrate was performed. ERK1/2
activity was measured by Western blot analysis with a phospho-specific
ERK antibody. After SDS-PAGE, phosphorylation of GST-NHE-1 (625-747)
and ERK1/2 was measured by densitometry in the linear range of film
development. A, representative Western blot with
anti-phospho-specific ERK1/2 antibody (top panel) and
anti-ERK1/2 (middle panel) and autoradiogram for p90RSK
activity (bottom panel). B, densitometric
analysis of ERK1/2 and GST-NHE-1 (625-747) phosphorylation. Results
were normalized to control (time = 0), which was arbitrarily set
to 1.0 (shown is mean ± S.D., n = 3).

View larger version (48K):
[in a new window]
Fig. 5.
H2O2-mediated
activation of p90RSK is calcium-dependent and partially
dependent on PKC. A, growth-arrested Jurkat cells were
treated with 1 µM phorbol 12,13-dibutyrate
(PDBu) for 16 h and then stimulated with 200 µM H2O2 for 2-5 min. ERK1/2 and
p90RSK activities were determined as described under "Materials and
Methods." Representative Western blots with anti-phospho-specific
ERK1/2 antibody (top panel) and anti-ERK1/2 (middle
panel) and autoradiogram for p90RSK activity (bottom
panel) of three performed are shown. B, growth-arrested
Jurkat cells were treated with Hanks' buffered salt solution or
Ca2+-free Hanks' buffered salt solution containg BAPTA-AM
for 30 min and then stimulated with 200 µM
H2O2 for 2-5 min. Cell lysates were prepared,
lysate proteins were immunoprecipitated with RSK2 antibody, and
in vitro kinase assay with GST-NHE-1 (625-747) as substrate
was performed. ERK1/2 activity was measured by Western blot analysis
with a phospho-specific ERK antibody. Representative Western blots with
anti-phospho-specific ERK1/2 antibody (top panel) and
anti-ERK1/2 (middle panel) and autoradiogram for p90RSK
activity (bottom panel) of three performed are shown.

View larger version (21K):
[in a new window]
Fig. 6.
H2O2 and thapsigargin
stimulation of p90RSK in Jurkat cells. Growth-arrested Jurkat
T-cells were treated with two different concentrations of thapsigargin
(TG) or 200 µM H2O2
for 5 min. Cell lysates were prepared, lysate proteins were
immunoprecipitated with RSK2 antibody, and in vitro kinase
assay with GST-NHE-1 (625-747) as substrate was performed. Data shown
are representative of experiments repeated two times with different
samples.

View larger version (48K):
[in a new window]
Fig. 7.
H2O2-stimulated
tyrosine phosphorylation and p90RSK activation by
H2O2 is inhibited by herbimycin A and PP1 in
Jurkat cells. A, growth-arrested Jurkat
cells were stimulated with 200 µM
H2O2 for 5 min and lysed, and Western blot was
performed with horseradish peroxidase-conjugated PY20
(anti-phosphotyrosine antibody). Data shown are representative of
experiments repeated two times with different samples. B,
growth-arrested Jurkat cells were pretreated with 0.1%
Me2SO for 16 h (control) and the indicated
concentrations of herbimycin A for 16 h or PP1 for 15 min. p90RSK
activity was determined by immune complex kinase assay using
[
-32P]ATP and measured after SDS-PAGE by
autoradiography. No difference in the amount of p90RSK was observed in
lysates from control and treated cells by Western blot analysis with
anti-p90RSK2 antibody (data not shown). Data shown are representative
of experiments repeated two times with different samples.
/
cells, whereas immunoreactive Fyn was
expressed to the same extent as in wild type cells. Likewise, there was
no immunoreactive Fyn in Fyn
/
cells, whereas there was no change in
expression of c-Src in Fyn
/
cells compared with wild type cells
(Fig. 8A).
H2O2 stimulated p90RSK activity in wild type
fibroblasts, which was maximal at 20 min (Fig. 8B, top
panel). In Src
/
fibroblasts, p90RSK activity increased with a
maximum 5.10 ± 0.95-fold increase 5 min after
H2O2 stimulation (Fig. 8B, middle
panel). In contrast, in Fyn
/
fibroblasts,
H2O2 failed to stimulate p90RSK activity at any
time (Fig. 8B, bottom panel). These results indicate that
H2O2 activation of p90RSK is dependent on Fyn
but not c-Src in fibroblasts.

View larger version (35K):
[in a new window]
Fig. 8.
H2O2 activation of
p90RSK is inhibited in Fyn
/
cells but not in c-Src
/
cells.
A, wild type mouse fibroblast (WT), Src
/
, and
Fyn
/
cells were harvested, and Western blot analysis was performed
on whole cell lysates using anti-Src antibody (left panel)
and anti-Fyn antibody (right panel). B, cells
were stimulated for the indicated times with 1 mM
H2O2, and p90RSK kinase activity was measured
by in vitro kinase assay using GST-NHE-1 (625-747), as
shown by the arrow. No difference in the amount of p90RSK
was observed in lysates from any of the cell lines by Western blot
analysis with anti-p90RSK2 (data not shown). C,
densitometric analysis of p90RSK kinase activity. Results were
normalized by arbitrarily setting the densitometry of control cells
(time = 0) to 1.0 (shown is mean ± S.D., n = 3).
/
, Fyn
/
, and wild type fibroblasts. Peak ERK1/2 kinase
activation occurred at 20 min in wild type fibroblasts (Fig.
9A, top panel). The ability of
H2O2 to stimulate ERK1/2 was attenuated in
Src
/
and Fyn
/
cells, when analyzed 5 min after
H2O2 addition. However, this inhibition was
entirely transient in nature. Maximal H2O2
activation of ERK1/2 occurred at 40 min in Fyn
/
and Src
/
cells
and was similar to ERK1/2 activation at 20 min in wild type cells (Fig.
9, B-D). These data suggest that there is an alternative
pathway for H2O2-mediated p90RSK activation in
addition to ERK1/2.

View larger version (34K):
[in a new window]
Fig. 9.
H2O2 activation of
ERK1/2 is delayed in Src
/
and Fyn
/
cells. Cells were
stimulated for the indicated times with 1 mM
H2O2, and ERK1/2 activity was measured by
Western blot analysis with a phospho-specific ERK1/2 antibody or
anti-ERK1/2 antibody. A-C, representative Western blots
with anti-phospho-specific ERK1/2 antibody (top panels) and
anti-ERK1/2 (bottom panels) are shown. D,
densitometric analysis of ERK1/2 phosphorylation. Results were
normalized to control (time = 0), which was arbitrarily set to 1.0 (shown is mean ± S.D., n = 3).

View larger version (42K):
[in a new window]
Fig. 10.
Effect of dominant negative Ras (RasN17) on
H2O2-mediated ERK1/2 and p90RSK activation in
Chinese hamster ovary (CHO) cells. Chinese
hamster ovary cells were transfected with RasN17 and 24 h later
washed with medium and maintained in serum-free medium for 24 h.
Cells were then treated with 1 mM
H2O2 for 5 and 20 min. ERK1/2 and p90RSK
activities were assayed as described in Fig. 2. Representative Western
blots with anti-phospho-specific ERK1/2 antibody (top panel)
and anti-ERK1/2 (middle panel) and autoradiogram for p90RSK
activity (bottom panel) of three performed are shown.
/
fibroblasts, activation of Ras by H2O2
was significantly decreased (Fig. 11B).

View larger version (26K):
[in a new window]
Fig. 11.
H2O2-induced Ras
activation: effect in Fyn
/
cells. Time course for
H2O2-induced Ras activation assayed by GST-RBD
(A and B) or Ras-GTP/(GTP+GDP) (C and
D). GTP-bound active Ras was isolated from lysates of
quiescent and H2O2-stimulated wild type
(WT) mouse fibroblast (A) and Fyn
/
cells
(B) by affinity precipitation with a GST-RBD fusion protein
(equal loading) was detected by Coomassie Brilliant Blue staining of
the polyacrylamide gel (bottom panels). GTP-bound Ras was
analyzed by Western blotting with anti-Ras antibody (top
panels). TCL, total cell lysate. There were no
differences in the amount of Ras present in the cell extracts as
determined by direct immunoblotting (data not shown). Shown is a
representative result of three experiments. C and
D, serum-starved subconfluent cultures of wild type
fibroblasts (C) and Fyn
/
cells (D) were
labeled in vivo with [32P]orthophosphate and
then treated for 2-20 min with H2O2, and
Ras-bound guanine nucleotides were isolated. Shown is an autoradiogram
of the extracted guanine nucleotides after thin-layer chromatography.
The positions of labeled GDP and GTP are indicated. The percentage of
Ras in the GTP-bound state is shown under the panels. Shown
is a representative result of two experiments.
/
cells (Fig.
11D), similar to results for binding to GST-RBD (Fig.
11B). These data indicate that Fyn is required for Ras
activation by H2O2.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/
fibroblasts,
there was no p90RSK activation in response to
H2O2. In contrast, in Src
/
fibroblasts, H2O2-mediated p90RSK activation was not
inhibited. 3) Transfection of dominant negative Ras blocked
H2O2 activation of p90RSK. 4) In Fyn
/
fibroblasts, H2O2 failed to activate Ras. Our
results are the first to show that Fyn and Ras but not Src are involved specifically in oxidative stress-mediated p90RSK activation.

View larger version (19K):
[in a new window]
Fig. 12.
Diagram of
H2O2-mediated signal transduction
pathways. Previously (49), we found that c-Src but not Fyn was
required for H2O2-mediated BMK1/ERK5
activation. In contrast, in the present study, we found that Fyn but
not c-Src was required for H2O2-mediated p90RSK
activation. These results indicate that c-Src and Fyn have separate
roles in oxidative stress-mediated signal transduction. Based on the
dominant negative Ras experiments, Ras is essential for both p90RSK and
ERK1/2 activation by H2O2.
In addition to activation of p90RSK by MEK1/2-ERK1/2 (path 1 in Fig. 12), the present study demonstrates the presence of another ROS-stimulated pathway that activates p90RSK independently of MEK1/2 (path 2 in Fig. 12). A MEK1/2-independent ERK1/2 activation pathway has been reported previously (50). It appears likely that H2O2-mediated p90RSK activation may also occur via an ERK1/2-independent pathway, because PD98059 inhibited H2O2-mediated ERK1/2 activation, but not p90RSK activation. A MEK1/2-ERK1/2-independent pathway is supported by findings that phosphorylation of Ser222 and Ser733 in p90RSK, which are required to activate p90RSK, is independent of ERK1/2 (19). A candidate kinase is 3-phosphoinositide-dependent protein kinase-1 based on the following information. Ser222 of p90RSK is in a motif homologous to residues of which the phosphorylation is important for activation of p70RSK, protein kinase B, and protein kinase C. Of interest, the residue equivalent to Ser222 of p90RSK in protein kinase B is phosphorylated by 3-phosphoinositide dependent protein kinase-1 (19). In fact, recently published data show that p90RSK activation is regulated by both the ERK1/2 pathway and a 3-phosphoinositide-dependent protein kinase-1-dependent pathway (51, 52).
The mechanisms by which specific Src family kinases are selectively
activated remains unknown. Src family kinases share several functional
domains, including an amino-terminal myristoylation sequence for
membrane targeting, a unique domain, SH2 and SH3 domains, a kinase
domain, and a carboxyl-terminal noncatalytic domain. Functional
properties of the amino-terminal unique region have not been well
defined. Current data indicate that this domain may be required for
specific interactions between particular Src family kinases and
downstream targets. Recently, several laboratories (including ours)
found that JAK activation is specifically regulated by Fyn but not Src
(53). We have also found that Src and Fyn specifically regulate BMK1
and JAK2, respectively (49, 53). In addition, Wary et al.
(54) reported that caveolin-1 functions as a membrane adapter to link
the integrin alpha subunit to Fyn, not to Src, and Puceat et
al. (55) have found that the anion Cl
/HCO3
exchanger (AE1)
associates with Fyn but not Src. It is not clear whether another Src
family kinase participates in ROS-induced p90RSK activation, but based
on our results, Fyn but not Src is an important regulator of p90RSK
activation. Future studies will be required to determine the nature of
this specificity for Src family kinases, focusing on the unique
amino-terminal domain.
It is not clear why the time course of
H2O2-mediated p90RSK activation is delayed in
Src
/
cells (Fig. 8, B and C). Previously, we
found that Fyn-JAK2 regulates the early phase of ERK1/2 activation, thus altering the time course for ERK1/2 activation (53). In a similar
manner, we believe that Src regulates the early phase of p90RSK
activation, and thus causes changes in activation time of p90RSK. As
another example, Oh et al. (56) have recently shown that Src
and Fyn both regulate SIRP-SHP-2 signaling, and SHP-2 has been reported
to regulate ERK1/2 activation. Therefore, it is possible that SHP-2 may
be involved in the early phase of p90RSK activation.
Understanding signal transduction pathways activated by
H2O2 is important, because
H2O2 is increased in hypertension,
inflammation, ischemia-reperfusion injury, and atherosclerosis. It has
become clear that the lesions of atherosclerosis represent a series of highly specific cellular and molecular responses that can be described as an inflammatory disease (57). Monocytes, leukocytes, and T
lymphocytes are markedly increased in regions of human atheroma (58,
59). How much H2O2 is produced by leukocytes
and monocytes in vivo is unknown; however, at sites of
inflammation, the production of ROS is enhanced, and
H2O2 can reach relatively high levels (0.1-1.0
mM) (60-64). Antioxidants such as vitamin E and probucol have had significant beneficial effects on coronary events (65) and
restenosis of atherosclerotic vessels that underwent angioplasty (66).
Therefore, to define the effect of H2O2 on
T-lymphocytes and other cells in the vessel wall will be important to
clarify the mechanisms that contribute to the initiation and
progression of cardiovascular disease (57).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. D. Shalloway for providing the
GST-RBD construct and Dr. Sheila M. Thomas for providing us Src
/
and Fyn
/
fibroblasts. We also thank Drs. C. Yan, E. Takahashi, H. Ueba, B. Gallis, and G. Daum for invaluable assistance and critical reading of this manuscript.
| |
FOOTNOTES |
|---|
* This study was supported by a grant from the Japanese Heart Foundation, Bayer Yakuhin Research Grant Abroad (to J.-i. A.), and National Institutes of Health Grants HL44721 and HL49192 (to B. C. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work.
¶ To whom correspondence should be addressed: Cardiology Unit, Box 679, 601 Elmwood Ave., University of Rochester School of Medicine and Dentistry, Rochester, NY 14642. Tel.: 716-273-1947; Fax: 716-273-1497; E-mail: bradford_berk@urmc.rochester.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ROS, reactive oxygen species; BMK1, big mitogen-activated protein kinase 1; CREB, cyclic AMP-response element-binding protein; ERK, extracellular signal-regulated kinase; MNC, human blood peripheral mononuclear cell; PAGE, polyacrylamide gel electrophoresis; RSK, ribosomal S6 kinase; NHE, Na+-H+ exchanger; GST, glutathione S-transferase; BAPTA-AM, bis-(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester; RBD, Raf binding domain; BAEC, bovine aortic endothelial cells.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Auch-Schwelk, W., Bossaller, C., Claus, M., Graf, K., Grafe, M., and Fleck, E. (1992) J. Cardiovasc. Pharmacol. 9, S62-S67 |
| 2. |
Stampfer, M. J.,
Hennekens, C. H.,
Manson, J. E.,
Colditz, G. A.,
Rosner, B.,
and Willett, W. C.
(1993)
N. Engl. J. Med.
328,
1444-1449 |
| 3. | Halliwell, B. (1989) Br. J. Exp. Pathol. 70, 737-757[Medline] [Order article via Infotrieve] |
| 4. | Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992) Cell 71, 1081-1091[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Baas, A. S.,
and Berk, B. C.
(1995)
Circ. Res.
77,
29-36 |
| 6. | Abe, J., and Berk, B. C. (1998) Trends Cardiovasc. Med. 8, 59-64[CrossRef] |
| 7. |
Rao, G. N.,
Lassegue, B.,
Griendling, K. K.,
Alexander, R. W.,
and Berk, B. C.
(1993)
Nucleic Acids Res.
21,
1259-1263 |
| 8. |
Sabri, A.,
Byron, K. L.,
Samarel, A. M.,
Bell, J.,
and Lucchesi, P. A.
(1998)
Circ. Res.
82,
1053-1062 |
| 9. |
Takahashi, E.,
Abe, J.,
and Berk, B. C.
(1997)
Circ. Res.
81,
268-273 |
| 10. |
Phan, V.,
Kusuhara, M.,
Lucchesi, P. A.,
and Berk, B. C.
(1997)
Hypertension
29,
1265-1272 |
| 11. |
Blenis, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5889-5892 |
| 12. |
Chen, R.-H.,
Chung, J.,
and Blenis, J.
(1991)
Mol. Cell. Biol.
11,
1861-1867 |
| 13. | Fisher, T. L., and Blenis, J. (1996) Mol. Cell. Biol. 16, 1212-1219[Abstract] |
| 14. |
Ghoda, L.,
Lin, X.,
and Greene, W. C.
(1997)
J. Biol. Chem.
272,
21281-21288 |
| 15. | Xing, J., Ginty, D. D., and Greenberg, M. E. (1996) Science 273, 959-963[Abstract] |
| 16. | Bolen, J. B., Rowley, R. B., Spana, C., and Tsygankov, A. Y. (1992) FASEB J. 6, 3403-3409[Abstract] |
| 17. | Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., and Yazaki, Y. (1997) J. Clin. Invest. 100, 1813-1821[Medline] [Order article via Infotrieve] |
| 18. |
Irani, K.,
Xia, Y.,
Zweier, J. L.,
Sollott, S. J.,
Der, C. J.,
Fearon, E. R.,
Sundaresan, M.,
Finkel, T.,
and Clermont-Goldschmidt, P. J.
(1997)
Science
275,
1649-1652 |
| 19. |
Dalby, K. N.,
Morrice, N.,
Caudwell, F. B.,
Avruch, J.,
and Cohen, P.
(1998)
J. Biol. Chem.
273,
1496-1505 |
| 20. |
Li, H. L.,
Forman, M. S.,
Kurosaki, T.,
and Pure, E.
(1997)
J. Biol. Chem.
272,
18200-18208 |
| 21. | Thomas, S. M., Soriano, P., and Imamoto, A. (1995) Nature 376, 267-271[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Schiemann, W. P.,
Bartoe, J. L.,
and Nathanson, N. M.
(1997)
J. Biol. Chem.
272,
16631-16636 |
| 23. |
Liao, D.-F.,
Monia, B.,
Dean, N.,
and Berk, B. C.
(1997)
J. Biol. Chem.
272,
6146-6150 |
| 24. | Boyum, A., Lovhaug, D., Tresland, L., and Nordlie, E. M. (1991) Scand. J. Immunol. 34, 697-712[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Tseng, H.,
Peterson, T. E.,
and Berk, B. C.
(1995)
Circ. Res.
77,
869-878 |
| 26. |
Abe, J.,
Kusuhara, M.,
Ulevitch, R. J.,
Berk, B. C.,
and Lee, J.-D.
(1996)
J. Biol. Chem.
271,
16586-16590 |
| 27. |
Berk, B. C.,
Brock, T. A.,
Gimbrone, M. A., Jr.,
and Alexander, R. W.
(1987)
J. Biol. Chem.
262,
5065-5072 |
| 28. | Fukuta, Y., Yoshizumi, M., Kitagawa, T., Hori, T., Katoh, I., Houchi, H., and Tamaki, T. (1998) Biochem. Pharmacol. 55, 481-487[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450 |
| 30. | Foschi, M., Chari, S., Dunn, M. J., and Sorokin, A. (1997) EMBO J. 16, 6439-51[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Satoh, T.,
Nakafuku, M.,
and Kaziro, Y.
(1992)
J. Biol. Chem.
267,
24149-24152 |
| 32. |
Satoh, T.,
Endo, M.,
Nakafuku, M.,
Nakamura, S.,
and Kaziro, Y.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
5993-5997 |
| 33. |
Griffith, C. E.,
Zhang, W.,
and Wange, R. L.
(1998)
J. Biol. Chem.
273,
10771-10776 |
| 34. |
Dang, A.,
Frost, J. A.,
and Cobb, M. H.
(1998)
J. Biol. Chem.
273,
19909-19913 |
| 35. |
Khokhlatchev, A.,
Xu, S.,
English, J.,
Wu, P.,
Schaefer, E.,
and Cobb, M. H.
(1997)
J. Biol. Chem.
272,
11057-11062 |
| 36. |
Pende, M.,
Fisher, T. L.,
Simpson, P. B.,
Russell, J. T.,
Blenis, J.,
and Gallo, V.
(1997)
J. Neurosci.
17,
1291-1301 |
| 37. |
Janssen, R. A. J.,
Veenstra, K. G.,
Jonasch, P.,
Jonasch, E.,
and Mier, J. W.
(1998)
J. Biol. Chem.
273,
32182-32186 |
| 38. |
Chen, Y.,
Shyu, J. F.,
Santhanagopal, A.,
Inoue, D.,
David, J.-P.,
Dixon, S. J.,
Horne, W. C.,
and Baron, R.
(1998)
J. Biol. Chem.
273,
19809-19816 |
| 39. |
Wennstrom, S.,
and Downward, J.
(1999)
Mol. Cell. Biol.
19,
4279-4288 |
| 40. |
Corbit, K. C.,
Foster, D. A.,
and Rosner, M. R.
(1999)
Mol. Cell. Biol.
19,
4209-4218 |